Pepto Bismol Chewable 5 Symptoms Relief

Manufacturer
JC World Bell Wholesale Co., Inc.
Effective date
2026-03-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:51:28

Label at a glance#

ProductPepto Bismol Chewable 5 Symptoms Relief
Active ingredientBISMUTH SUBSALICYLATE
Label structure9 sections

Indications and uses

relieves • travelers diarrhea • diarrhea • upset stomach due to overindulgence in food and drink, including: • heartburn • indigestion • nausea • gas • belching • fullness

Dosage and administration

• chew or dissolve in mouth • adults and children 12 years and over: • 2 tablets (1 dose) every 1/2 hour or 4 tablets (2 doses) every hour as needed for diarrhea • 2 tablets (1 dose) every 1/2 hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea) • do not exceed 8 doses (16 tablets) in 24 hours • use until diarrhea stops but not more than 2 days • children under 12 years: ask a doctor •...

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Bismuth subsalicylate 262 mg

Purpose

OTC - PURPOSE SECTION

Upset stomach reliever and antidiarrheal

Uses

INDICATIONS & USAGE SECTION

relieves • travelers diarrhea • diarrhea
• upset stomach due to overindulgence in food and drink, including:
• heartburn • indigestion • nausea • gas • belching • fullness

Warnings

WARNINGS SECTION

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert: Contains salicylate. Do not take if you are

• allergic to salicylates (including aspirin) • taking other salicylate products

Do not use if

OTC - DO NOT USE SECTION

you have
• an ulcer • a bleeding problem • bloody or black stool

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

• fever • mucus in the stool

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking any drug for

• anticoagulation (thinning the blood) • diabetes • gout • arthritis

When using this product

OTC - WHEN USING SECTION

a temporary, but harmless, darkening of the stool and/or tongue may occur

Stop use and ask a doctor if

OTC - STOP USE SECTION

• symptoms get worse or last more than 2 days
• ringing in the ears or loss of hearing occurs • diarrhea lasts more than 2 days

If pregnant or breast feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• chew or dissolve in mouth • adults and children 12 years and over:
• 2 tablets (1 dose) every 1/2 hour or 4 tablets (2 doses) every hour as needed for diarrhea
• 2 tablets (1 dose) every 1/2 hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)
• do not exceed 8 doses (16 tablets) in 24 hours • use until diarrhea stops but not more than 2 days
• children under 12 years: ask a doctor • drink plenty of clear fluids to help prevent dehydration caused by diarrhea

Other information

SPL UNCLASSIFIED SECTION

• each tablet contains: calcium 140 mg, magnesium 9 mg • salicylate 101 mg • low sodium
• avoid excessive heat (over 104°F or 40°C)

Inactive ingredients

INACTIVE INGREDIENT SECTION

calcium carbonate, D&C Red No. 27 aluminum lake, flavor, magnesium stearate, mannitol, povidone, saccharin sodium, talc

Questions?

OTC - QUESTIONS SECTION

1-800-717-3786

Package Labeling:50269-555-01

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Outer Package02Outer Package02Inner Package02Inner Package02

Package Labeling:50269-555-02

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Outer Package03Outer Package03Inner Package03Inner Package03

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
308761bismuth subsalicylate 262 MG Chewable TabletPSN1
211151Pepto-Bismol 262 MG Chewable TabletPSN1
211151bismuth subsalicylate 262 MG Chewable Tablet [Pepto-bismol]SBD1
308761bismuth subsalicylate 262 MG Chewable TabletSCD1
211151Pepto-bismol 262 MG Chewable TabletSY1
211151Pepto-Bismol InstaCool 262 MG Chewable TabletSY1
211151Pepto-Bismol To-Go 262 MG Chewable TabletSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50269-555-01Pepto Bismol Chewable 5 Symptoms Relief6 in 1 BOXTABLET, CHEWABLE61
50269-555-01Pepto Bismol Chewable 5 Symptoms Relief1 in 1 BLISTER PACKTABLET, CHEWABLE11
50269-555-02Pepto Bismol Chewable 5 Symptoms Relief6 in 1 BOXTABLET, CHEWABLE61
50269-555-02Pepto Bismol Chewable 5 Symptoms Relief1 in 1 BLISTER PACKTABLET, CHEWABLE11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50269-55550269-555-01, 50269-555-02
58933-011

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pepto Bismol CHEWABLESBISMUTH SUBSALICYLATEProcter & Gamble Manufactura S de RL de CV06fce961-5e57-b640-e063-6394a90a9e8a2026-10-05WarningsExact identifier
ndc (product): 58933-011
4d79f5cc-3e10-e1be-e063-6394a90a89cad9ce1f32-7e18-471a-adb6-5992c59602f62026-03-20WarningsExact identifier
spl id: 4d79f5cc-3e10-e1be-e063-6394a90a89ca
spl set id: d9ce1f32-7e18-471a-adb6-5992c59602f6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.